| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $414K | +404.9% |
| SG&A Expense | $1.9M | +18.2% |
| Operating Income | -$2.3M | -36.7% |
| Net Income | -$2.6M | -243.7% |
| EPS (Basic) | -$0.23 | -35.3% |
| EPS (Diluted) | -$0.23 | -35.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $4.2M | +4027.7% |
| Total Assets | $5.8M | +497.7% |
| Current Liabilities | $992K | -58.8% |
| Total Liabilities | $992K | -67.4% |
| Stockholders' Equity | $4.8M | +329.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.0M | -4982.7% |
| Financing Cash Flow | $5.1M | +1308.0% |